Rasagiline identified as potential Parkinson’s treatment
February 27, 2018, 4:39 pm
A toddler from Afghanistan is treated by Save A Child's Heart in Holon. Photo courtesy of Save A Child's Heart
Prof. Moussa Youdim with the drug he developed. Photo by Nati Shohat
• Technion Prof. Moussa Youdim publishes a paper claiming the compound Rasagiline can fight Parkinson’s disease. Three years later, Israeli drug company Teva Pharmaceuticals develops Azilect and begins marketing it in Europe (2005) and the United States (2006).
• Jerusalem celebrates its 3,000th anniversary of King David establishing it as his capital city.
For over 16 years, ISRAEL21c has brought you the faces and places of Israel every day, spreading the word about Israel to millions of people in virtually every country around the globe. First of its kind, our content is originally researched, written and produced by seasoned experts directly from Israel.
We cannot do this without financial support from people like you. Become a GEM member and enjoy exclusive briefings from our staff and more - for $18 a month.
Read more on: